nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—CYP3A4—Clindamycin—malaria	0.0561	0.268	CbGbCtD
Ruxolitinib—CYP3A4—Sulfadiazine—malaria	0.0322	0.154	CbGbCtD
Ruxolitinib—CYP3A4—Artemether—malaria	0.0274	0.131	CbGbCtD
Ruxolitinib—CYP3A4—Proguanil—malaria	0.0257	0.123	CbGbCtD
Ruxolitinib—CYP3A4—Doxycycline—malaria	0.0244	0.116	CbGbCtD
Ruxolitinib—CYP3A4—Quinine—malaria	0.0166	0.0792	CbGbCtD
Ruxolitinib—CYP3A4—Quinidine—malaria	0.0146	0.0696	CbGbCtD
Ruxolitinib—CYP3A4—Dapsone—malaria	0.0126	0.06	CbGbCtD
Ruxolitinib—DCLK3—blood plasma—malaria	0.00775	0.0243	CbGeAlD
Ruxolitinib—CAMK1—blood plasma—malaria	0.00638	0.02	CbGeAlD
Ruxolitinib—MARK2—blood plasma—malaria	0.0062	0.0194	CbGeAlD
Ruxolitinib—Pancytopenia—Pyrimethamine—malaria	0.00553	0.0384	CcSEcCtD
Ruxolitinib—Haematuria—Pyrimethamine—malaria	0.00495	0.0344	CcSEcCtD
Ruxolitinib—PLK1—hematopoietic system—malaria	0.00452	0.0142	CbGeAlD
Ruxolitinib—ROCK1—blood plasma—malaria	0.00451	0.0141	CbGeAlD
Ruxolitinib—Pancytopenia—Proguanil—malaria	0.00431	0.0299	CcSEcCtD
Ruxolitinib—DCLK3—hematopoietic system—malaria	0.00429	0.0134	CbGeAlD
Ruxolitinib—PRKG2—kidney—malaria	0.00413	0.0129	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Proguanil—malaria	0.00383	0.0266	CcSEcCtD
Ruxolitinib—MAP3K2—blood plasma—malaria	0.00356	0.0112	CbGeAlD
Ruxolitinib—CAMK1—hematopoietic system—malaria	0.00353	0.0111	CbGeAlD
Ruxolitinib—PRKG2—digestive system—malaria	0.00351	0.011	CbGeAlD
Ruxolitinib—MARK2—hematopoietic system—malaria	0.00343	0.0107	CbGeAlD
Ruxolitinib—Thrombocytopenia—Pyrimethamine—malaria	0.00324	0.0225	CcSEcCtD
Ruxolitinib—Malnutrition—Proguanil—malaria	0.00316	0.0219	CcSEcCtD
Ruxolitinib—JAK2—blood plasma—malaria	0.00315	0.00987	CbGeAlD
Ruxolitinib—PLK1—digestive system—malaria	0.00314	0.00985	CbGeAlD
Ruxolitinib—JAK1—saliva-secreting gland—malaria	0.00303	0.00951	CbGeAlD
Ruxolitinib—JAK3—hematopoietic system—malaria	0.00291	0.00913	CbGeAlD
Ruxolitinib—JAK1—hematopoietic system—malaria	0.0029	0.00907	CbGeAlD
Ruxolitinib—DAPK2—saliva-secreting gland—malaria	0.00289	0.00907	CbGeAlD
Ruxolitinib—PLK4—hematopoietic system—malaria	0.00288	0.00902	CbGeAlD
Ruxolitinib—DCLK3—blood—malaria	0.00284	0.0089	CbGeAlD
Ruxolitinib—TAOK3—blood plasma—malaria	0.00277	0.00867	CbGeAlD
Ruxolitinib—STK16—hematopoietic system—malaria	0.00272	0.00851	CbGeAlD
Ruxolitinib—HIPK2—hematopoietic system—malaria	0.0027	0.00847	CbGeAlD
Ruxolitinib—CLK2—saliva-secreting gland—malaria	0.0027	0.00845	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00267	0.0185	CcSEcCtD
Ruxolitinib—PRKG2—liver—malaria	0.00261	0.00818	CbGeAlD
Ruxolitinib—Nervous system disorder—Proguanil—malaria	0.00253	0.0176	CcSEcCtD
Ruxolitinib—Skin disorder—Proguanil—malaria	0.00251	0.0174	CcSEcCtD
Ruxolitinib—PLK3—blood—malaria	0.0025	0.00783	CbGeAlD
Ruxolitinib—ROCK1—hematopoietic system—malaria	0.00249	0.00781	CbGeAlD
Ruxolitinib—PRKCE—liver—malaria	0.00244	0.00764	CbGeAlD
Ruxolitinib—DYRK1A—hematopoietic system—malaria	0.00243	0.00762	CbGeAlD
Ruxolitinib—NUAK2—saliva-secreting gland—malaria	0.00243	0.0076	CbGeAlD
Ruxolitinib—BMPR2—hematopoietic system—malaria	0.00242	0.00759	CbGeAlD
Ruxolitinib—MARK2—digestive system—malaria	0.00238	0.00747	CbGeAlD
Ruxolitinib—JAK1—kidney—malaria	0.00237	0.00744	CbGeAlD
Ruxolitinib—RPS6KA6—liver—malaria	0.00234	0.00734	CbGeAlD
Ruxolitinib—PLK1—liver—malaria	0.00234	0.00734	CbGeAlD
Ruxolitinib—CAMK1—blood—malaria	0.00234	0.00733	CbGeAlD
Ruxolitinib—MARK2—blood—malaria	0.00227	0.00711	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Proguanil—malaria	0.00223	0.0155	CcSEcCtD
Ruxolitinib—HIPK2—kidney—malaria	0.00222	0.00694	CbGeAlD
Ruxolitinib—LRRK2—hematopoietic system—malaria	0.00215	0.00673	CbGeAlD
Ruxolitinib—TAOK2—blood—malaria	0.0021	0.00658	CbGeAlD
Ruxolitinib—Neutropenia—Clindamycin—malaria	0.0021	0.0146	CcSEcCtD
Ruxolitinib—Pancytopenia—Quinine—malaria	0.00209	0.0145	CcSEcCtD
Ruxolitinib—Pancytopenia—Quinidine—malaria	0.00209	0.0145	CcSEcCtD
Ruxolitinib—PRKG2—brain—malaria	0.00207	0.00649	CbGeAlD
Ruxolitinib—Neutropenia—Quinine—malaria	0.00206	0.0143	CcSEcCtD
Ruxolitinib—Neutropenia—Quinidine—malaria	0.00206	0.0143	CcSEcCtD
Ruxolitinib—ROCK1—kidney—malaria	0.00204	0.0064	CbGeAlD
Ruxolitinib—MAP3K7—saliva-secreting gland—malaria	0.00204	0.0064	CbGeAlD
Ruxolitinib—Body temperature increased—Proguanil—malaria	0.00204	0.0142	CcSEcCtD
Ruxolitinib—JAK3—digestive system—malaria	0.00203	0.00635	CbGeAlD
Ruxolitinib—JAK1—digestive system—malaria	0.00201	0.00631	CbGeAlD
Ruxolitinib—DCLK1—digestive system—malaria	0.00201	0.00631	CbGeAlD
Ruxolitinib—TYK2—saliva-secreting gland—malaria	0.00201	0.00629	CbGeAlD
Ruxolitinib—DYRK1A—kidney—malaria	0.00199	0.00625	CbGeAlD
Ruxolitinib—BMPR2—kidney—malaria	0.00199	0.00622	CbGeAlD
Ruxolitinib—MKNK2—saliva-secreting gland—malaria	0.00198	0.0062	CbGeAlD
Ruxolitinib—GRK1—brain—malaria	0.00198	0.00619	CbGeAlD
Ruxolitinib—MAP3K2—hematopoietic system—malaria	0.00197	0.00617	CbGeAlD
Ruxolitinib—PLK3—liver—malaria	0.00196	0.00613	CbGeAlD
Ruxolitinib—Urinary tract infection—Clindamycin—malaria	0.00194	0.0135	CcSEcCtD
Ruxolitinib—PRKCE—brain—malaria	0.00193	0.00606	CbGeAlD
Ruxolitinib—JAK3—blood—malaria	0.00193	0.00605	CbGeAlD
Ruxolitinib—JAK1—blood—malaria	0.00192	0.00601	CbGeAlD
Ruxolitinib—TYK2—hematopoietic system—malaria	0.00191	0.006	CbGeAlD
Ruxolitinib—PLK4—blood—malaria	0.00191	0.00597	CbGeAlD
Ruxolitinib—STK16—digestive system—malaria	0.00189	0.00592	CbGeAlD
Ruxolitinib—MKNK2—hematopoietic system—malaria	0.00189	0.00592	CbGeAlD
Ruxolitinib—IRAK1—hematopoietic system—malaria	0.00189	0.00592	CbGeAlD
Ruxolitinib—Epistaxis—Clindamycin—malaria	0.00189	0.0131	CcSEcCtD
Ruxolitinib—Pancytopenia—Quinidine barbiturate—malaria	0.00189	0.0131	CcSEcCtD
Ruxolitinib—Pancytopenia—Pentoxifylline—malaria	0.00188	0.0131	CcSEcCtD
Ruxolitinib—HIPK2—digestive system—malaria	0.00188	0.00589	CbGeAlD
Ruxolitinib—CAMK1D—blood—malaria	0.00187	0.00587	CbGeAlD
Ruxolitinib—PLK1—brain—malaria	0.00186	0.00582	CbGeAlD
Ruxolitinib—RPS6KA6—brain—malaria	0.00186	0.00582	CbGeAlD
Ruxolitinib—MAST1—brain—malaria	0.00186	0.00582	CbGeAlD
Ruxolitinib—Neutropenia—Quinidine barbiturate—malaria	0.00186	0.0129	CcSEcCtD
Ruxolitinib—JAK1—bone marrow—malaria	0.00186	0.00582	CbGeAlD
Ruxolitinib—PLK4—bone marrow—malaria	0.00184	0.00578	CbGeAlD
Ruxolitinib—RET—hematopoietic system—malaria	0.00184	0.00577	CbGeAlD
Ruxolitinib—DAPK2—blood—malaria	0.00183	0.00573	CbGeAlD
Ruxolitinib—CAMK1—liver—malaria	0.00183	0.00573	CbGeAlD
Ruxolitinib—STK16—blood—malaria	0.0018	0.00564	CbGeAlD
Ruxolitinib—DAPK2—bone marrow—malaria	0.00177	0.00555	CbGeAlD
Ruxolitinib—Haemoglobin—Quinidine—malaria	0.00177	0.0123	CcSEcCtD
Ruxolitinib—Haemoglobin—Quinine—malaria	0.00177	0.0123	CcSEcCtD
Ruxolitinib—Infestation—Pentoxifylline—malaria	0.00177	0.0123	CcSEcCtD
Ruxolitinib—Infestation NOS—Pentoxifylline—malaria	0.00177	0.0123	CcSEcCtD
Ruxolitinib—DCLK3—brain—malaria	0.00176	0.00552	CbGeAlD
Ruxolitinib—Haemorrhage—Quinine—malaria	0.00176	0.0122	CcSEcCtD
Ruxolitinib—Haemorrhage—Quinidine—malaria	0.00176	0.0122	CcSEcCtD
Ruxolitinib—LRRK2—kidney—malaria	0.00176	0.00552	CbGeAlD
Ruxolitinib—MAP3K3—saliva-secreting gland—malaria	0.00176	0.00551	CbGeAlD
Ruxolitinib—JAK2—hematopoietic system—malaria	0.00174	0.00546	CbGeAlD
Ruxolitinib—ROCK1—digestive system—malaria	0.00173	0.00543	CbGeAlD
Ruxolitinib—DAPK3—blood—malaria	0.00172	0.00539	CbGeAlD
Ruxolitinib—CLK2—blood—malaria	0.0017	0.00534	CbGeAlD
Ruxolitinib—BMPR2—digestive system—malaria	0.00168	0.00528	CbGeAlD
Ruxolitinib—MAP3K3—hematopoietic system—malaria	0.00168	0.00526	CbGeAlD
Ruxolitinib—Thrombocytopenia—Sulfadiazine—malaria	0.00168	0.0116	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Pentoxifylline—malaria	0.00167	0.0116	CcSEcCtD
Ruxolitinib—Epistaxis—Pentoxifylline—malaria	0.00167	0.0116	CcSEcCtD
Ruxolitinib—ROCK1—blood—malaria	0.00165	0.00518	CbGeAlD
Ruxolitinib—CLK2—bone marrow—malaria	0.00165	0.00517	CbGeAlD
Ruxolitinib—TAOK2—liver—malaria	0.00164	0.00515	CbGeAlD
Ruxolitinib—Headache—Proguanil—malaria	0.00162	0.0112	CcSEcCtD
Ruxolitinib—TAOK3—saliva-secreting gland—malaria	0.0016	0.00503	CbGeAlD
Ruxolitinib—Haemoglobin—Quinidine barbiturate—malaria	0.0016	0.0111	CcSEcCtD
Ruxolitinib—Haemoglobin—Pentoxifylline—malaria	0.00159	0.0111	CcSEcCtD
Ruxolitinib—Haemorrhage—Quinidine barbiturate—malaria	0.00159	0.011	CcSEcCtD
Ruxolitinib—Haemorrhage—Pentoxifylline—malaria	0.00159	0.011	CcSEcCtD
Ruxolitinib—TYK2—kidney—malaria	0.00157	0.00492	CbGeAlD
Ruxolitinib—PLK3—brain—malaria	0.00155	0.00486	CbGeAlD
Ruxolitinib—Flatulence—Clindamycin—malaria	0.00154	0.0107	CcSEcCtD
Ruxolitinib—NUAK2—blood—malaria	0.00153	0.00481	CbGeAlD
Ruxolitinib—Malnutrition—Quinine—malaria	0.00153	0.0106	CcSEcCtD
Ruxolitinib—Malnutrition—Quinidine—malaria	0.00153	0.0106	CcSEcCtD
Ruxolitinib—TAOK3—hematopoietic system—malaria	0.00153	0.0048	CbGeAlD
Ruxolitinib—RET—kidney—malaria	0.00151	0.00473	CbGeAlD
Ruxolitinib—CAMK2G—digestive system—malaria	0.00151	0.00472	CbGeAlD
Ruxolitinib—JAK1—liver—malaria	0.0015	0.0047	CbGeAlD
Ruxolitinib—LTK—brain—malaria	0.0015	0.00469	CbGeAlD
Ruxolitinib—NUAK2—bone marrow—malaria	0.00148	0.00465	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Sulfadiazine—malaria	0.00148	0.0103	CcSEcCtD
Ruxolitinib—CAMK1D—liver—malaria	0.00146	0.00459	CbGeAlD
Ruxolitinib—PHKG2—liver—malaria	0.00146	0.00456	CbGeAlD
Ruxolitinib—CAMK1—brain—malaria	0.00145	0.00455	CbGeAlD
Ruxolitinib—Anaemia—Clindamycin—malaria	0.00144	0.01	CcSEcCtD
Ruxolitinib—BMP2K—blood—malaria	0.00144	0.0045	CbGeAlD
Ruxolitinib—CAMK2G—blood—malaria	0.00144	0.0045	CbGeAlD
Ruxolitinib—JAK2—kidney—malaria	0.00143	0.00447	CbGeAlD
Ruxolitinib—LRRK2—blood—malaria	0.00142	0.00446	CbGeAlD
Ruxolitinib—MARK2—brain—malaria	0.00141	0.00441	CbGeAlD
Ruxolitinib—STK16—liver—malaria	0.00141	0.00441	CbGeAlD
Ruxolitinib—HIPK2—liver—malaria	0.0014	0.00439	CbGeAlD
Ruxolitinib—CAMK2G—bone marrow—malaria	0.00139	0.00435	CbGeAlD
Ruxolitinib—BMP2K—bone marrow—malaria	0.00139	0.00435	CbGeAlD
Ruxolitinib—Malnutrition—Quinidine barbiturate—malaria	0.00138	0.0096	CcSEcCtD
Ruxolitinib—LRRK2—bone marrow—malaria	0.00138	0.00431	CbGeAlD
Ruxolitinib—Flatulence—Pentoxifylline—malaria	0.00136	0.00944	CcSEcCtD
Ruxolitinib—Body temperature increased—Sulfadiazine—malaria	0.00135	0.0094	CcSEcCtD
Ruxolitinib—DAPK3—liver—malaria	0.00135	0.00422	CbGeAlD
Ruxolitinib—CLK2—liver—malaria	0.00133	0.00418	CbGeAlD
Ruxolitinib—TYK2—digestive system—malaria	0.00133	0.00417	CbGeAlD
Ruxolitinib—MKNK2—digestive system—malaria	0.00131	0.00412	CbGeAlD
Ruxolitinib—MAP3K2—blood—malaria	0.0013	0.00409	CbGeAlD
Ruxolitinib—TAOK2—brain—malaria	0.0013	0.00408	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.0013	0.00899	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.0013	0.00899	CcSEcCtD
Ruxolitinib—ROCK1—liver—malaria	0.00129	0.00405	CbGeAlD
Ruxolitinib—MAP3K7—blood—malaria	0.00129	0.00405	CbGeAlD
Ruxolitinib—RET—digestive system—malaria	0.00128	0.00402	CbGeAlD
Ruxolitinib—Anaemia—Pentoxifylline—malaria	0.00128	0.00886	CcSEcCtD
Ruxolitinib—TYK2—blood—malaria	0.00127	0.00397	CbGeAlD
Ruxolitinib—MAP3K2—bone marrow—malaria	0.00126	0.00395	CbGeAlD
Ruxolitinib—DYRK1A—liver—malaria	0.00126	0.00395	CbGeAlD
Ruxolitinib—BMPR2—liver—malaria	0.00125	0.00393	CbGeAlD
Ruxolitinib—TAOK3—kidney—malaria	0.00125	0.00393	CbGeAlD
Ruxolitinib—MKNK2—blood—malaria	0.00125	0.00392	CbGeAlD
Ruxolitinib—IRAK1—blood—malaria	0.00125	0.00392	CbGeAlD
Ruxolitinib—MAP3K7—bone marrow—malaria	0.00125	0.00392	CbGeAlD
Ruxolitinib—Thrombocytopenia—Clindamycin—malaria	0.00125	0.00867	CcSEcCtD
Ruxolitinib—TYK2—bone marrow—malaria	0.00123	0.00385	CbGeAlD
Ruxolitinib—Nervous system disorder—Quinine—malaria	0.00123	0.00851	CcSEcCtD
Ruxolitinib—Nervous system disorder—Quinidine—malaria	0.00123	0.00851	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Quinine—malaria	0.00123	0.0085	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Quinidine—malaria	0.00123	0.0085	CcSEcCtD
Ruxolitinib—RET—blood—malaria	0.00122	0.00383	CbGeAlD
Ruxolitinib—Skin disorder—Quinidine—malaria	0.00122	0.00843	CcSEcCtD
Ruxolitinib—Skin disorder—Quinine—malaria	0.00122	0.00843	CcSEcCtD
Ruxolitinib—Pruritus—Sulfadiazine—malaria	0.00121	0.00841	CcSEcCtD
Ruxolitinib—MKNK2—bone marrow—malaria	0.00121	0.0038	CbGeAlD
Ruxolitinib—IRAK1—bone marrow—malaria	0.00121	0.0038	CbGeAlD
Ruxolitinib—JAK2—digestive system—malaria	0.00121	0.0038	CbGeAlD
Ruxolitinib—NUAK2—liver—malaria	0.0012	0.00376	CbGeAlD
Ruxolitinib—JAK3—brain—malaria	0.0012	0.00375	CbGeAlD
Ruxolitinib—JAK1—brain—malaria	0.00119	0.00373	CbGeAlD
Ruxolitinib—DCLK1—brain—malaria	0.00119	0.00373	CbGeAlD
Ruxolitinib—PLK4—brain—malaria	0.00118	0.00371	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00117	0.00812	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00117	0.0081	CcSEcCtD
Ruxolitinib—CAMK1D—brain—malaria	0.00116	0.00364	CbGeAlD
Ruxolitinib—PHKG2—brain—malaria	0.00116	0.00362	CbGeAlD
Ruxolitinib—JAK2—blood—malaria	0.00115	0.00362	CbGeAlD
Ruxolitinib—DAPK2—brain—malaria	0.00114	0.00356	CbGeAlD
Ruxolitinib—BMP2K—liver—malaria	0.00112	0.00352	CbGeAlD
Ruxolitinib—CAMK2G—liver—malaria	0.00112	0.00352	CbGeAlD
Ruxolitinib—Infection—Pentoxifylline—malaria	0.00112	0.00777	CcSEcCtD
Ruxolitinib—STK16—brain—malaria	0.00112	0.0035	CbGeAlD
Ruxolitinib—JAK2—bone marrow—malaria	0.00112	0.0035	CbGeAlD
Ruxolitinib—LRRK2—liver—malaria	0.00111	0.00349	CbGeAlD
Ruxolitinib—MAP3K3—blood—malaria	0.00111	0.00349	CbGeAlD
Ruxolitinib—HIPK2—brain—malaria	0.00111	0.00348	CbGeAlD
Ruxolitinib—Nervous system disorder—Quinidine barbiturate—malaria	0.00111	0.00768	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Quinidine barbiturate—malaria	0.00111	0.00767	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Pentoxifylline—malaria	0.0011	0.00766	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Clindamycin—malaria	0.0011	0.00764	CcSEcCtD
Ruxolitinib—Fatigue—Clindamycin—malaria	0.0011	0.00763	CcSEcCtD
Ruxolitinib—Skin disorder—Quinidine barbiturate—malaria	0.0011	0.00761	CcSEcCtD
Ruxolitinib—Skin disorder—Pentoxifylline—malaria	0.0011	0.0076	CcSEcCtD
Ruxolitinib—MAP3K19—brain—malaria	0.00109	0.00341	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Quinine—malaria	0.00108	0.0075	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Quinidine—malaria	0.00108	0.0075	CcSEcCtD
Ruxolitinib—MAP3K3—bone marrow—malaria	0.00108	0.00337	CbGeAlD
Ruxolitinib—Headache—Sulfadiazine—malaria	0.00107	0.00745	CcSEcCtD
Ruxolitinib—DAPK3—brain—malaria	0.00107	0.00335	CbGeAlD
Ruxolitinib—TAOK3—digestive system—malaria	0.00106	0.00334	CbGeAlD
Ruxolitinib—CLK2—brain—malaria	0.00106	0.00331	CbGeAlD
Ruxolitinib—Body temperature increased—Dapsone—malaria	0.00104	0.00723	CcSEcCtD
Ruxolitinib—ROCK1—brain—malaria	0.00103	0.00321	CbGeAlD
Ruxolitinib—MAP3K2—liver—malaria	0.00102	0.00319	CbGeAlD
Ruxolitinib—TAOK3—blood—malaria	0.00101	0.00318	CbGeAlD
Ruxolitinib—MAP3K7—liver—malaria	0.00101	0.00317	CbGeAlD
Ruxolitinib—Body temperature increased—Clindamycin—malaria	0.00101	0.007	CcSEcCtD
Ruxolitinib—DYRK1A—brain—malaria	0.001	0.00313	CbGeAlD
Ruxolitinib—BMPR2—brain—malaria	0.000996	0.00312	CbGeAlD
Ruxolitinib—TYK2—liver—malaria	0.000992	0.00311	CbGeAlD
Ruxolitinib—Body temperature increased—Quinidine—malaria	0.000989	0.00686	CcSEcCtD
Ruxolitinib—Body temperature increased—Quinine—malaria	0.000989	0.00686	CcSEcCtD
Ruxolitinib—TAOK3—bone marrow—malaria	0.000981	0.00307	CbGeAlD
Ruxolitinib—MKNK2—liver—malaria	0.000979	0.00307	CbGeAlD
Ruxolitinib—IRAK1—liver—malaria	0.000979	0.00307	CbGeAlD
Ruxolitinib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000975	0.00676	CcSEcCtD
Ruxolitinib—NUAK2—brain—malaria	0.000952	0.00298	CbGeAlD
Ruxolitinib—Asthenia—Clindamycin—malaria	0.000915	0.00635	CcSEcCtD
Ruxolitinib—Pruritus—Clindamycin—malaria	0.000903	0.00626	CcSEcCtD
Ruxolitinib—JAK2—liver—malaria	0.000902	0.00283	CbGeAlD
Ruxolitinib—Asthenia—Quinine—malaria	0.000898	0.00623	CcSEcCtD
Ruxolitinib—Asthenia—Quinidine—malaria	0.000898	0.00623	CcSEcCtD
Ruxolitinib—Body temperature increased—Quinidine barbiturate—malaria	0.000893	0.00619	CcSEcCtD
Ruxolitinib—Body temperature increased—Pentoxifylline—malaria	0.000891	0.00618	CcSEcCtD
Ruxolitinib—BMP2K—brain—malaria	0.000891	0.00279	CbGeAlD
Ruxolitinib—CAMK2G—brain—malaria	0.000891	0.00279	CbGeAlD
Ruxolitinib—Pruritus—Quinine—malaria	0.000885	0.00614	CcSEcCtD
Ruxolitinib—Pruritus—Quinidine—malaria	0.000885	0.00614	CcSEcCtD
Ruxolitinib—LRRK2—brain—malaria	0.000883	0.00277	CbGeAlD
Ruxolitinib—MAP3K3—liver—malaria	0.00087	0.00273	CbGeAlD
Ruxolitinib—Dizziness—Clindamycin—malaria	0.000844	0.00585	CcSEcCtD
Ruxolitinib—CYP3A4—blood plasma—malaria	0.000841	0.00263	CbGeAlD
Ruxolitinib—Dizziness—Quinine—malaria	0.000828	0.00574	CcSEcCtD
Ruxolitinib—Dizziness—Quinidine—malaria	0.000828	0.00574	CcSEcCtD
Ruxolitinib—Headache—Dapsone—malaria	0.000826	0.00573	CcSEcCtD
Ruxolitinib—Asthenia—Quinidine barbiturate—malaria	0.00081	0.00562	CcSEcCtD
Ruxolitinib—MAP3K2—brain—malaria	0.000809	0.00254	CbGeAlD
Ruxolitinib—Asthenia—Pentoxifylline—malaria	0.000809	0.00561	CcSEcCtD
Ruxolitinib—MAP3K7—brain—malaria	0.000802	0.00251	CbGeAlD
Ruxolitinib—Headache—Clindamycin—malaria	0.000799	0.00554	CcSEcCtD
Ruxolitinib—Pruritus—Quinidine barbiturate—malaria	0.000799	0.00554	CcSEcCtD
Ruxolitinib—Pruritus—Pentoxifylline—malaria	0.000798	0.00553	CcSEcCtD
Ruxolitinib—TAOK3—liver—malaria	0.000793	0.00248	CbGeAlD
Ruxolitinib—TYK2—brain—malaria	0.000787	0.00247	CbGeAlD
Ruxolitinib—Headache—Quinidine—malaria	0.000784	0.00544	CcSEcCtD
Ruxolitinib—Headache—Quinine—malaria	0.000784	0.00544	CcSEcCtD
Ruxolitinib—IRAK1—brain—malaria	0.000777	0.00243	CbGeAlD
Ruxolitinib—MKNK2—brain—malaria	0.000777	0.00243	CbGeAlD
Ruxolitinib—RET—brain—malaria	0.000758	0.00237	CbGeAlD
Ruxolitinib—Dizziness—Quinidine barbiturate—malaria	0.000747	0.00518	CcSEcCtD
Ruxolitinib—Dizziness—Pentoxifylline—malaria	0.000746	0.00517	CcSEcCtD
Ruxolitinib—JAK2—brain—malaria	0.000716	0.00224	CbGeAlD
Ruxolitinib—Headache—Quinidine barbiturate—malaria	0.000708	0.00491	CcSEcCtD
Ruxolitinib—Headache—Pentoxifylline—malaria	0.000706	0.0049	CcSEcCtD
Ruxolitinib—MAP3K3—brain—malaria	0.00069	0.00216	CbGeAlD
Ruxolitinib—TAOK3—brain—malaria	0.000629	0.00197	CbGeAlD
Ruxolitinib—CYP3A4—hematopoietic system—malaria	0.000465	0.00146	CbGeAlD
Ruxolitinib—CYP3A4—kidney—malaria	0.000381	0.00119	CbGeAlD
Ruxolitinib—CYP3A4—digestive system—malaria	0.000323	0.00101	CbGeAlD
Ruxolitinib—CYP3A4—blood—malaria	0.000308	0.000965	CbGeAlD
Ruxolitinib—CYP3A4—liver—malaria	0.000241	0.000755	CbGeAlD
Ruxolitinib—CAMK2G—Immune System—CRP—malaria	5.31e-05	0.000162	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—TLR4—malaria	5.26e-05	0.000161	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CRP—malaria	5.18e-05	0.000158	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CRP—malaria	5.17e-05	0.000158	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—DHFR—malaria	5.12e-05	0.000156	CbGpPWpGaD
Ruxolitinib—JAK2—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	5.11e-05	0.000156	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—TLR4—malaria	5.11e-05	0.000156	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—TLR4—malaria	5.09e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—CD36—malaria	5.07e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IFNG—malaria	5.04e-05	0.000154	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL18—malaria	5.02e-05	0.000153	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—IL6—malaria	5.01e-05	0.000153	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—IL6—malaria	5.01e-05	0.000153	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	5.01e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD40LG—malaria	5e-05	0.000153	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—IL2—malaria	4.98e-05	0.000152	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TLR9—malaria	4.98e-05	0.000152	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—CD36—malaria	4.98e-05	0.000152	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—TLR4—malaria	4.97e-05	0.000152	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—IL6—malaria	4.97e-05	0.000152	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—TLR4—malaria	4.96e-05	0.000151	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD8A—malaria	4.95e-05	0.000151	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—IL6—malaria	4.92e-05	0.00015	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—IL6—malaria	4.9e-05	0.00015	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CRP—malaria	4.89e-05	0.000149	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD4—malaria	4.88e-05	0.000149	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—ICAM1—malaria	4.88e-05	0.000149	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NOS2—malaria	4.88e-05	0.000149	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—IL6—malaria	4.86e-05	0.000149	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TLR9—malaria	4.83e-05	0.000148	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—ICAM1—malaria	4.76e-05	0.000146	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HLA-B—malaria	4.76e-05	0.000145	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—IL6—malaria	4.7e-05	0.000144	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TLR9—malaria	4.69e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—TLR4—malaria	4.69e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD36—malaria	4.66e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—IL6—malaria	4.62e-05	0.000141	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—HLA-B—malaria	4.57e-05	0.00014	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—ICAM1—malaria	4.56e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Toll-Like Receptors Cascades—IL6—malaria	4.56e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—IL6—malaria	4.56e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ACKR1—malaria	4.54e-05	0.000139	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FCGR2A—malaria	4.53e-05	0.000138	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL1B—malaria	4.49e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—ICAM1—malaria	4.49e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD36—malaria	4.48e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL2—malaria	4.48e-05	0.000137	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	4.44e-05	0.000136	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—KDR—malaria	4.39e-05	0.000134	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—IL6—malaria	4.36e-05	0.000133	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—IL2—malaria	4.34e-05	0.000133	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—IL6—malaria	4.29e-05	0.000131	CbGpPWpGaD
Ruxolitinib—TYK2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	4.29e-05	0.000131	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL2—malaria	4.22e-05	0.000129	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CRP—malaria	4.21e-05	0.000129	CbGpPWpGaD
Ruxolitinib—JAK1—Axon guidance—IL6—malaria	4.19e-05	0.000128	CbGpPWpGaD
Ruxolitinib—ROCK1—Axon guidance—IL6—malaria	4.12e-05	0.000126	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—IL6—malaria	4.1e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—NOS2—malaria	4.09e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—IL6—malaria	4.08e-05	0.000125	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—IL6—malaria	4.06e-05	0.000124	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IFNG—malaria	4.05e-05	0.000124	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CRP—malaria	4.04e-05	0.000123	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—IL6—malaria	4.04e-05	0.000123	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—TLR4—malaria	4.03e-05	0.000123	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL2—malaria	3.96e-05	0.000121	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL2—malaria	3.94e-05	0.00012	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD4—malaria	3.91e-05	0.00012	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—DHFR—malaria	3.88e-05	0.000119	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—TLR4—malaria	3.87e-05	0.000118	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ICAM1—malaria	3.87e-05	0.000118	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL18—malaria	3.82e-05	0.000117	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD40LG—malaria	3.8e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—IL6—malaria	3.8e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—IL6—malaria	3.8e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—IL6—malaria	3.8e-05	0.000116	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—IL6—malaria	3.76e-05	0.000115	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD8A—malaria	3.76e-05	0.000115	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—IL6—malaria	3.73e-05	0.000114	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—IL6—malaria	3.71e-05	0.000114	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IFNG—malaria	3.71e-05	0.000113	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD4—malaria	3.71e-05	0.000113	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL18—malaria	3.71e-05	0.000113	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—malaria	3.7e-05	0.000113	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD40LG—malaria	3.69e-05	0.000113	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TLR9—malaria	3.66e-05	0.000112	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—IL2—malaria	3.66e-05	0.000112	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD8A—malaria	3.65e-05	0.000112	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—malaria	3.64e-05	0.000111	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—IL6—malaria	3.63e-05	0.000111	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IFNG—malaria	3.62e-05	0.000111	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HLA-B—malaria	3.62e-05	0.000111	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL1B—malaria	3.61e-05	0.00011	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CD4—malaria	3.61e-05	0.00011	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD4—malaria	3.6e-05	0.00011	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL2—malaria	3.6e-05	0.00011	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL18—malaria	3.6e-05	0.00011	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—KDR—malaria	3.59e-05	0.00011	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL2—malaria	3.58e-05	0.00011	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD4—malaria	3.58e-05	0.00011	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD40LG—malaria	3.58e-05	0.000109	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IL6—malaria	3.58e-05	0.000109	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD36—malaria	3.55e-05	0.000108	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD8A—malaria	3.54e-05	0.000108	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NOS2—malaria	3.54e-05	0.000108	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—IL6—malaria	3.52e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-B—malaria	3.51e-05	0.000107	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD4—malaria	3.5e-05	0.000107	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD4—malaria	3.49e-05	0.000107	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IL6—malaria	3.47e-05	0.000106	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD36—malaria	3.44e-05	0.000105	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IFNG—malaria	3.42e-05	0.000104	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—IL6—malaria	3.41e-05	0.000104	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-B—malaria	3.41e-05	0.000104	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IL6—malaria	3.37e-05	0.000103	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—IL6—malaria	3.36e-05	0.000103	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD4—malaria	3.35e-05	0.000102	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD36—malaria	3.34e-05	0.000102	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—IL6—malaria	3.33e-05	0.000102	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL2—malaria	3.33e-05	0.000102	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL1B—malaria	3.31e-05	0.000101	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD4—malaria	3.3e-05	0.000101	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL2—malaria	3.3e-05	0.000101	CbGpPWpGaD
Ruxolitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	3.25e-05	9.94e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL1B—malaria	3.23e-05	9.88e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL2—malaria	3.22e-05	9.84e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CRP—malaria	3.2e-05	9.77e-05	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—IL2—malaria	3.15e-05	9.63e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CRP—malaria	3.1e-05	9.49e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—IL2—malaria	3.1e-05	9.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—IL6—malaria	3.09e-05	9.44e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TLR4—malaria	3.07e-05	9.37e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL1B—malaria	3.05e-05	9.32e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL2—malaria	3.04e-05	9.29e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—KDR—malaria	3.03e-05	9.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CRP—malaria	3.01e-05	9.2e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—IL6—malaria	3.01e-05	9.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—IL6—malaria	2.99e-05	9.13e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—TLR4—malaria	2.98e-05	9.1e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IFNG—malaria	2.94e-05	8.99e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ICAM1—malaria	2.94e-05	8.98e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—IL6—malaria	2.94e-05	8.98e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TLR4—malaria	2.89e-05	8.82e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL2—malaria	2.86e-05	8.74e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ICAM1—malaria	2.85e-05	8.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—malaria	2.84e-05	8.68e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL2—malaria	2.81e-05	8.6e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL18—malaria	2.81e-05	8.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD40LG—malaria	2.8e-05	8.55e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—malaria	2.79e-05	8.52e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ICAM1—malaria	2.77e-05	8.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD8A—malaria	2.77e-05	8.46e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—malaria	2.73e-05	8.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—malaria	2.73e-05	8.34e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-B—malaria	2.66e-05	8.14e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—IL6—malaria	2.64e-05	8.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL6—malaria	2.63e-05	8.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—malaria	2.62e-05	8.02e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—malaria	2.62e-05	8.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS2—malaria	2.61e-05	7.99e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—malaria	2.61e-05	7.99e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD36—malaria	2.61e-05	7.98e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—KDR—malaria	2.61e-05	7.97e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—IL6—malaria	2.59e-05	7.91e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—KDR—malaria	2.56e-05	7.84e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL6—malaria	2.48e-05	7.57e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—malaria	2.35e-05	7.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—malaria	2.34e-05	7.16e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—malaria	2.33e-05	7.12e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—malaria	2.33e-05	7.11e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—malaria	2.32e-05	7.08e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DHODH—malaria	2.26e-05	6.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR4—malaria	2.26e-05	6.89e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—malaria	2.24e-05	6.84e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—malaria	2.2e-05	6.74e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—malaria	2.17e-05	6.64e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—malaria	2.16e-05	6.61e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—malaria	2.16e-05	6.6e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—malaria	2.12e-05	6.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—malaria	2.11e-05	6.45e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—malaria	2.11e-05	6.44e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—malaria	2.11e-05	6.44e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—malaria	2.1e-05	6.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—malaria	2.07e-05	6.33e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—malaria	2.03e-05	6.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—malaria	2.01e-05	6.13e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—malaria	1.99e-05	6.1e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—malaria	1.99e-05	6.07e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—KDR—malaria	1.98e-05	6.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—malaria	1.98e-05	6.05e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—malaria	1.96e-05	6e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—malaria	1.95e-05	5.97e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—malaria	1.95e-05	5.97e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—malaria	1.95e-05	5.95e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—malaria	1.94e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—malaria	1.94e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—malaria	1.94e-05	5.92e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—malaria	1.93e-05	5.9e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—KDR—malaria	1.92e-05	5.88e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC4A1—malaria	1.92e-05	5.87e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—malaria	1.89e-05	5.79e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—malaria	1.89e-05	5.77e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—malaria	1.88e-05	5.74e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—malaria	1.87e-05	5.72e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—KDR—malaria	1.87e-05	5.7e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DECR1—malaria	1.81e-05	5.52e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—malaria	1.79e-05	5.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—malaria	1.76e-05	5.39e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—malaria	1.69e-05	5.16e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—malaria	1.68e-05	5.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—malaria	1.67e-05	5.11e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—malaria	1.66e-05	5.08e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—malaria	1.65e-05	5.05e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—malaria	1.65e-05	5.03e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HBB—malaria	1.63e-05	4.99e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—malaria	1.6e-05	4.89e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—malaria	1.59e-05	4.86e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—malaria	1.54e-05	4.7e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—malaria	1.48e-05	4.51e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—malaria	1.47e-05	4.49e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—malaria	1.47e-05	4.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—malaria	1.46e-05	4.47e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—KDR—malaria	1.46e-05	4.46e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PKLR—malaria	1.46e-05	4.45e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—malaria	1.42e-05	4.33e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—malaria	1.37e-05	4.18e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—G6PD—malaria	1.3e-05	3.97e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—malaria	1.28e-05	3.93e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—malaria	1.25e-05	3.81e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—malaria	1.24e-05	3.79e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—malaria	1.21e-05	3.7e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—malaria	1.17e-05	3.57e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—malaria	1.15e-05	3.53e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—malaria	1.13e-05	3.47e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—malaria	1.1e-05	3.36e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—malaria	1.05e-05	3.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—malaria	9.93e-06	3.04e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HPGDS—malaria	9.9e-06	3.03e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—malaria	9.77e-06	2.99e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—malaria	9.45e-06	2.89e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—malaria	9.41e-06	2.87e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DHFR—malaria	9.18e-06	2.81e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SCARB1—malaria	9.09e-06	2.78e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—malaria	8.59e-06	2.63e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—malaria	7.94e-06	2.43e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—malaria	7.55e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—malaria	7.33e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—malaria	7.11e-06	2.17e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CD36—malaria	5.7e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—malaria	5.56e-06	1.7e-05	CbGpPWpGaD
